Drug Trial Radar · NCT07455383
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Apr 6, 2026
Primary completion
May 2027
Study completion Jun 2027
Sponsor
- Lead sponsor
- Alkermes, Inc.Industry
- Sponsor type
- Industry
- First posted
- Mar 6, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to measure decreases in daytime sleepiness, cataplexy (sudden loss of muscle tone), and disease symptoms in participants with NT1 when taking ALKS 2680 tablets compared with placebo tablets.
Conditions
- Narcolepsy Type 1
Interventions
ALKS 2680 Dose 1Drug
Participants will receive ALKS 2680 tablets, orally, daily, for 12 weeks
ALKS 2680 Dose 2Drug
Participants will receive ALKS 2680 tablets, orally, daily, for 12 weeks
PlaceboDrug
Participants will receive ALKS 2680-matching placebo tablets, orally, for 12 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in mean sleep latency (MSL) on Maintenance of Wakefulness Test (MWT) from baseline to Week 12 by dose levelTime frame: Baseline to Week 12
Locations
66 sites in 15 countries. Site status is shown where the registry gives one.
Alkermes Investigational Site
Cullman, Alabama · Recruiting
Alkermes Investigational Site
Phoenix, Arizona · Recruiting
Alkermes Investigational Site
Tucson, Arizona · Recruiting
Alkermes Investigational Site
Los Angeles, California · Recruiting
Alkermes Investigational Site
Boulder, Colorado · Recruiting
Alkermes Investigational Site
Brandon, Florida · Recruiting
Alkermes Investigational Site
Miami, Florida · Recruiting
Alkermes Investigational Site
Winter Park, Florida · Recruiting
Alkermes Investigational Site
Macon, Georgia · Recruiting
Alkermes Investigational Site
Kansas City, Kansas · Recruiting
Alkermes Investigational Site
Newton, Massachusetts · Recruiting
Alkermes Investigational Site
Lansing, Michigan · Recruiting
Alkermes Investigational Site
Novi, Michigan · Recruiting
Alkermes Investigational Site
St Louis, Missouri · Recruiting
Alkermes Investigational Site
Middletown, New Jersey · Terminated
Alkermes Investigational Site
New Hyde Park, New York · Recruiting
Alkermes Investigational Site
Charlotte, North Carolina · Recruiting
Alkermes Investigational Site
Cincinnati, Ohio · Recruiting
Alkermes Investigational Site
Wyomissing, Pennsylvania · Recruiting
Alkermes Investigational Site
Charleston, South Carolina · Recruiting
Alkermes Investigational Site
Columbia, South Carolina · Recruiting
Alkermes Investigational Site
Austin, Texas · Recruiting
Alkermes Investigational Site
San Antonio, Texas · Recruiting
Alkermes Investigational Site
Sugar Land, Texas · Recruiting
Alkermes Investigational Site
Madison, Wisconsin · Recruiting
Alkermes Investigational Site
Macquarie Park, New South Wales, Australia · Recruiting
Alkermes Investigational Site
Bruges, Belgium · Recruiting
Alkermes Investigational Site
Edegem, Belgium · Recruiting
Alkermes Investigational Site
Ghent, Belgium · Recruiting
Alkermes Investigational Site
Namur, Belgium · Recruiting
Alkermes Investigational Site
Markham, Ontario, Canada · Recruiting
Alkermes Investigational Site
Toronto, Ontario, Canada · Recruiting
Alkermes Investigational Site
Montreal, Quebec, Canada · Recruiting
Alkermes Investigational Site
Klecany, Central Bohemia, Czechia · Recruiting
Alkermes Investigational Site
Prague, Prague, Czechia · Recruiting
Alkermes Investigational Site
Helsinki, Finland · Recruiting
Alkermes Investigational Site
Bordeaux, France · Recruiting
Alkermes Investigational Site
Lyon, France · Recruiting
Alkermes Investigational Site
Montpellier, France · Recruiting
Alkermes Investigational Site
Nantes, France · Recruiting
Showing 40 of 66 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.